Miami, Florida Clinical Trials

A listing of Miami, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab

This is an open-label, multicenter study that includes a main study for all participants enrolled and an optional cerebrospinal fluid (CSF) sub-study. Self-identified African American (AA) and Hispanic or Latin American (HA) participants with a diagnosis of relapsing multiple sclerosis (RMS) will be enrolled. The treating neurologist must make an …

University of Miami Miller School of Medicine
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +30 other locations
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

This is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study.The study consists of 3 periods:Screening period: 2 to 4 weeks.Treatment period: 24 weeks.Post-intervention follow-up period: 16 weeks. The study duration will be approximately 42 to 44 weeks for each participant (including screening, treatment, and follow-up periods).The total number of planned …

Direct Helpers Research Center- Site Number : 8400015
 (8.8 away) Contact site
  • 0 views
  • 14 May, 2025
  • +5 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

migraine
lasmiditan
preventive medication
treatment regimen
ly573144
Jackson Memorial Hospital
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

Investigational Site Number 8400020
 (7.9 away)
  • 0 views
  • 19 Feb, 2024
  • +31 other locations
High-Speed Yoga and Executive Function

The purpose of this research study is to establish if a novel high-speed yoga program which incorporates visual cues can make a positive change in the participant's ability to make decisions and move as measured by several cognitive, balance and functional tests. It has been shown that yoga can improve …

stroke
cancer
cognitive assessment
parkinson's disease
hoehn and yahr scale
Max Orovitz Laboratories
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Baumann Cosmetic & Research Institute, Inc
 (3.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)

The purpose of this study is to assess the hematologic effects of IMG-7289 therapy in ET and PV patients who require platelet, White Blood Cell (WBC) or Red Blood Cell (RBC) control, and have failed at least one standard therapy.

myeloproliferative disorder
chronic myeloproliferative disease
polycythemia vera
blast count
essential thrombocythemia
University of Miami
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

amyloid
galantamine
donepezil
alzheimer's disease
memantine
Optimus U
 (2.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

chest x-ray
treatment regimen
ct scan
acute respiratory syndrome (sars)
covid-19
University of Miami Health System
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +13 other locations
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.

fibrosis
fibroscan
vcte
fatty liver
hepatic fibrosis
La Salud Research, Inc.
 (7.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations